Immunological effects of adoptive immunotherapy with IL-2: an overview.
Kradin
R
R
Department of Pathology, Massachusetts General Hospital, Boston.
Yamin
R
R
Kurnick
J
J
D000818:Animals; D002478:Cells, Cultured; D006801:Humans; D007108:Immune Tolerance; D007116:Immunization, Passive / Q000009:adverse effects; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000637:transplantation*; D008222:Lymphokines / Q000378:metabolism; D008231:Lymphopenia / Q000209:etiology; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D014581:Urticaria / Q000209:etiology
D007376:Interleukin-2; D008222:Lymphokines; D011994:Recombinant Proteins